The US Food and Drug Administration approved the "fast track" designation for two experimental vaccines developed by Pfizer and BioNTech. The designation enables a more efficient development process between companies and regulatory agencies and makes pharmaceutical companies eligible for expedited approval.
Fast track to approve vaccines from Pfizer and BioNTech
2020-07-14T17:05:20.513Z
The US Food and Drug Administration approved the "fast track" designation for two experimental vaccines developed by Pfizer and BioNTech. The designation ...